{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:03:20Z","timestamp":1776949400904,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica","doi-asserted-by":"crossref","award":["2010-2271"],"award-info":[{"award-number":["2010-2271"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008478","name":"Instituto Nacional del C\u00e1ncer","doi-asserted-by":"crossref","award":["2013-2015"],"award-info":[{"award-number":["2013-2015"]}],"id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008478","name":"Instituto Nacional del C\u00e1ncer","doi-asserted-by":"crossref","award":["11220120100383CO01"],"award-info":[{"award-number":["11220120100383CO01"]}],"id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.colsurfb.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T13:24:11Z","timestamp":1467552251000},"page":"624-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Sustained-release hydrogels of topotecan for retinoblastoma"],"prefix":"10.1016","volume":"146","author":[{"given":"Paula","family":"Taich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela A.","family":"Moretton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jose","family":"Del Sole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Bernabeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan O.","family":"Croxatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Oppezzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo L.","family":"Chantada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego A.","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Schaiquevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2016.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2015.3108","article-title":"Treatment of retinoblastoma in 2015 agreement and disagreement","volume":"133","author":"Abramson","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-med-061312-123455","article-title":"Retinoblastoma: saving life with vision","volume":"65","author":"Abramson","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opge.25.1.37.28996","article-title":"Activity of topotecan in retinoblastoma","volume":"25","author":"Chantada","year":"2004","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0020","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-05-0849","article-title":"Topotecan combination chemotherapy in two new rodent models of retinoblastoma","volume":"11","author":"Laurie","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00173681","article-title":"Topoisomerase I interactive drugs in children with cancer","volume":"14","author":"Stewart","year":"1996","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jnci\/90.7.505","article-title":"Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts","volume":"90","author":"Zamboni","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2010.03.009","article-title":"Pharmacokinetic analysis of topotecan after intra-vitreal injection implications for retinoblastoma treatment","volume":"91","author":"Buitrago","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0045","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1167\/iovs.06-1152","article-title":"Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy","volume":"48","author":"Carcaboso","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0050","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1167\/iovs.09-4050","article-title":"Episcleral implants for topotecan delivery to the posterior segment of the eye","volume":"51","author":"Carcaboso","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1167\/iovs.07-0653","article-title":"Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma","volume":"49","author":"Tsui","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2009.08.006","article-title":"Development of a highly stable and targetable nanoliposomal formulation of topotecan","volume":"141","author":"Drummond","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2011.02.012","article-title":"Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release","volume":"79","author":"Souza","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2011.07.008","article-title":"Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel","volume":"156","author":"Chang","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0080","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1002\/jps.21780","article-title":"Biodegradable In situ gel-forming controlled drug delivery system based on thermosensitive PCL\u2fffPEG\u2fffPCL hydrogel: part 1 \u2fff synthesis, characterization, and acute toxicity evaluation","volume":"98","author":"Chang Yang Gong","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.colsurfb.2010.05.016","article-title":"Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles","volume":"79","author":"Moretton","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0090","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.actbio.2009.05.025","article-title":"Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior","volume":"5","author":"Gong","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0095","first-page":"1","article-title":"Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA\/CPMP\/EWP\/280\/96 Corr1)","volume":"44","author":"EMA","year":"2013","journal-title":"Eur. Med. Agency (EMEA)"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0100","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1167\/iovs.14-16239","article-title":"Pharmacokinetics, safety, and efficacy of intravitreal digoxin in preclinical models for retinoblastoma","volume":"56","author":"Winter","year":"2015","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0110","series-title":"Microdialysis Drug Dev.","first-page":"13","article-title":"Recovery and calibration techniques","author":"de Lange","year":"2013"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exer.2013.01.002","article-title":"Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma","volume":"108","author":"Buitrago","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0120","first-page":"1","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma a preclinical and clinical study","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0141-8130(99)00043-4","article-title":"In vitro and in vivo degradation of lactic acid-based interference screws used in cruciate ligament reconstruction","volume":"25","author":"Schwach","year":"1999","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-3659(02)00008-1","article-title":"Biodegradable injectable in situ forming drug delivery systems","volume":"80","author":"Hatefi","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejpb.2008.01.033","article-title":"Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars","volume":"69","author":"Loughlin","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0140","series-title":"ADAPT 5 User\u2fffs Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software","author":"Wang","year":"2009"},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0145","first-page":"321","article-title":"Pathophysiology of glaucoma in uveitis","volume":"101","author":"Ritch","year":"1981","journal-title":"Trans. Ophthalmol. Soc. U. K."},{"key":"10.1016\/j.colsurfb.2016.07.001_bib0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516304933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516304933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T07:38:43Z","timestamp":1556609923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776516304933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"alternative-id":["S0927776516304933"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.001","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained-release hydrogels of topotecan for retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}